NCT06622304View on ClinicalTrials.gov

Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels

CompletedOBSERVATIONAL
Enrollment

250,736

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

September 11, 2024

Conditions
HypertensionDyslipidemiasInflammatory ResponseChronic InflammationInflammatory Cytokines
Trial Locations (1)

510120

Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

OTHER

lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT06622304 - Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels | Biotech Hunter | Biotech Hunter